raloxifene hydrochloride has been researched along with simvastatin in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (50.00) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Flevari, P; Koniavitou, K; Kremastinos, DT; Kroupis, C; Kyriakides, ZS; Sbarouni, E | 1 |
| Ciaccia, AV; Davidson, MH; Insull, W; Keech, CA; Kulkarni, PM; Siddhanti, S | 1 |
| Kalgutkar, AS; Obach, RS; Soglia, JR; Zhao, SX | 1 |
| Connolly, JG; Gagne, JJ | 1 |
| Bettencourt, A; Martin, V | 1 |
| Fervers, F; Henrich, D; Kontradowitz, K; Leiblein, M; Marzi, I; Seebach, C | 1 |
1 review(s) available for raloxifene hydrochloride and simvastatin
| Article | Year |
|---|---|
Bone regeneration: Biomaterials as local delivery systems with improved osteoinductive properties.
Topics: Alendronate; Anti-Bacterial Agents; Biocompatible Materials; Blood Platelets; Bone and Bones; Bone Regeneration; Drug Carriers; Humans; Intercellular Signaling Peptides and Proteins; Raloxifene Hydrochloride; Simvastatin | 2018 |
2 trial(s) available for raloxifene hydrochloride and simvastatin
| Article | Year |
|---|---|
The effects of raloxifene and simvastatin on plasma lipids and endothelium.
Topics: Aged; Cell Adhesion Molecules; Coronary Artery Disease; Cross-Over Studies; Double-Blind Method; Endothelium, Vascular; Female; Forearm; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Lipids; Middle Aged; Postmenopause; Raloxifene Hydrochloride; Regional Blood Flow; Selective Estrogen Receptor Modulators; Simvastatin; Vascular Resistance | 2003 |
Effects of raloxifene and low-dose simvastatin coadministration on plasma lipids in postmenopausal women with primary hypercholesterolemia.
Topics: Adult; Aged; Aged, 80 and over; Double-Blind Method; Female; Humans; Hypercholesterolemia; Lipids; Lipoproteins; Middle Aged; Placebos; Postmenopause; Raloxifene Hydrochloride; Simvastatin | 2005 |
3 other study(ies) available for raloxifene hydrochloride and simvastatin
| Article | Year |
|---|---|
Can in vitro metabolism-dependent covalent binding data in liver microsomes distinguish hepatotoxic from nonhepatotoxic drugs? An analysis of 18 drugs with consideration of intrinsic clearance and daily dose.
Topics: Acetaminophen; Binding Sites; Buspirone; Carbamazepine; Diclofenac; Diphenhydramine; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Hepatocytes; Humans; Indomethacin; Meloxicam; Microsomes, Liver; Molecular Structure; Paroxetine; Piperazines; Propranolol; Raloxifene Hydrochloride; Simvastatin; Structure-Activity Relationship; Thiazines; Thiazoles; Ticrynafen; Toxicity Tests; Triazoles | 2008 |
Comparison of Calipers for Matching on the Disease Risk Score.
Topics: Aged; Aged, 80 and over; Alendronate; Anti-Inflammatory Agents, Non-Steroidal; Bone Density Conservation Agents; Cardiovascular Diseases; Cohort Studies; Computer Simulation; Cyclooxygenase 2 Inhibitors; Epidemiologic Methods; Ezetimibe; Female; Gastrointestinal Hemorrhage; Humans; Male; Medicare; Models, Theoretical; Monte Carlo Method; Odds Ratio; Osteoporotic Fractures; Prognosis; Propensity Score; Raloxifene Hydrochloride; Risk Assessment; Simvastatin; United States | 2016 |
Do antiosteoporotic drugs improve bone regeneration in vivo?
Topics: Absorptiometry, Photon; Alendronate; Alkaline Phosphatase; Animals; Biomechanical Phenomena; Blotting, Western; Bone Density; Bone Density Conservation Agents; Bone Morphogenetic Protein 2; Bone Regeneration; Bony Callus; Calcium-Regulating Hormones and Agents; Collagen Type I; Female; Femur; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Interleukin-6; Macrophage Colony-Stimulating Factor; Osteocalcin; Osteogenesis; Osteogenesis, Distraction; Parathyroid Hormone; Raloxifene Hydrochloride; RANK Ligand; Rats; Reverse Transcriptase Polymerase Chain Reaction; Simvastatin; Thiophenes; Tomography, X-Ray Computed | 2020 |